Literature DB >> 16895790

Mechanism by which avenanthramide-c, a polyphenol of oats, blocks cell cycle progression in vascular smooth muscle cells.

Lin Nie1, Mitchell Wise, David Peterson, Mohsen Meydani.   

Abstract

Previously, we reported that avenanthramide-c (Avn-c), one of the major avenanthramides, polyphenols of oats, inhibited the serum-induced proliferation of vascular smooth muscle cells (SMC), which is an important process in the initiation and development of atherosclerosis. In the present study, we further investigated its cell cycle inhibitory mechanism. Rat embryonic aortic smooth muscle cell line A10 was used in this study. Flow cytometry analysis revealed that treatment of A10 cells with 80 muM Avn-c arrested the cell cycle in G1 phase as indicated by an increase in the number of cells in G1 phase and a decrease in the number of cells in S phase. This cell cycle arrest was associated with a decrease in the phosphorylation of retinoblastoma protein (pRb), whose hyperphosphorylation is a hallmark of the G1 to S transition in the cell cycle. The inhibition of pRb phosphorylation with Avn-c was accompanied by a decrease in cyclin D1 expression and an increase in cyclin-dependent kinase inhibitor p21cip1 expression, without significant changes in p27kip1 expression. Furthermore, Avn-c treatment increased the expression level and stability of p53 protein, which could account for the increase of p21cip1 expression. Our results demonstrate for the first time that Avn-c, which is a unique polyphenol found in oats, arrests SMC proliferation at G1 phase by upregulating the p53-p21cip1 pathway and inhibiting pRB phosphorylation. This inhibitory effect of Avn-c on SMC proliferation is an additional indication for the potential health benefit of oat consumption in the prevention of coronary heart disease beyond its known effect through lowering blood cholesterol.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16895790     DOI: 10.1016/j.freeradbiomed.2006.04.020

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  10 in total

Review 1.  Herbal Approach for Management of Atherosclerosis: a Review.

Authors:  Sanjiv Singh
Journal:  Curr Atheroscler Rep       Date:  2019-02-28       Impact factor: 5.113

2.  Avenanthramide supplementation attenuates eccentric exercise-inflicted blood inflammatory markers in women.

Authors:  Ryan T Koenig; Jonathan R Dickman; Choung-Hun Kang; Tianou Zhang; Yi-Fang Chu; Li Li Ji
Journal:  Eur J Appl Physiol       Date:  2015-08-20       Impact factor: 3.078

3.  Production of hydroxycinnamoyl anthranilates from glucose in Escherichia coli.

Authors:  Aymerick Eudes; Darmawi Juminaga; Edward E K Baidoo; F William Collins; Jay D Keasling; Dominique Loqué
Journal:  Microb Cell Fact       Date:  2013-06-28       Impact factor: 5.328

Review 4.  Anti-Hypertensive Herbs and Their Mechanisms of Action: Part II.

Authors:  M Akhtar Anwar; Sara S Al Disi; Ali H Eid
Journal:  Front Pharmacol       Date:  2016-03-08       Impact factor: 5.810

5.  Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner.

Authors:  Gretel G Pellegrini; Cynthya C Morales; Taylor C Wallace; Lilian I Plotkin; Teresita Bellido
Journal:  Nutrients       Date:  2016-07-11       Impact factor: 5.717

Review 6.  Processing of oat: the impact on oat's cholesterol lowering effect.

Authors:  Myriam M-L Grundy; Anthony Fardet; Susan M Tosh; Gillian T Rich; Peter J Wilde
Journal:  Food Funct       Date:  2018-02-12       Impact factor: 5.396

7.  Cytoprotective effects of Avenathramide C against oxidative and inflammatory stress in normal human dermal fibroblasts.

Authors:  Chenxuan Wang; Christopher H Eskiw
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

8.  Avenanthramide supplementation attenuates exercise-induced inflammation in postmenopausal women.

Authors:  Ryan Koenig; Jonathan R Dickman; Chounghun Kang; Tianou Zhang; Yi-Fang Chu; Li Li Ji
Journal:  Nutr J       Date:  2014-03-19       Impact factor: 3.271

9.  Avenanthramide-C reduces the viability of MDA-MB-231 breast cancer cells through an apoptotic mechanism.

Authors:  Jordan Hastings; Jason Kenealey
Journal:  Cancer Cell Int       Date:  2017-10-18       Impact factor: 5.722

Review 10.  Biological Activities, Health Benefits, and Therapeutic Properties of Avenanthramides: From Skin Protection to Prevention and Treatment of Cerebrovascular Diseases.

Authors:  Andrea Perrelli; Luca Goitre; Anna Maria Salzano; Andrea Moglia; Andrea Scaloni; Saverio Francesco Retta
Journal:  Oxid Med Cell Longev       Date:  2018-08-23       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.